Melina Arnold1, Deependra Singh1, Mathieu Laversanne1, Jerome Vignat1, Salvatore Vaccarella1, Filip Meheus1, Anne E Cust2,3, Esther de Vries4, David C Whiteman5, Freddie Bray1. 1. Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France. 2. The Daffodil Centre, The University of Sydney with Cancer Council New South Wales, Sydney, Australia. 3. Melanoma Institute Australia, The University of Sydney, Sydney, Australia. 4. Department of Clinical Epidemiology and Biostatistics, Pontificia Universidad Javeriana, Bogota, Colombia. 5. Cancer Control Group, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
Abstract
Importance: Despite many cases being preventable, cutaneous melanoma remains the most serious skin cancer worldwide. Understanding the scale and profile of the disease is vital to concentrate and reinforce global prevention efforts. Objective: To examine global patterns of cutaneous melanoma in 2020 and to provide projected estimates of cases and deaths by 2040. Design, Setting, and Participants: This population-based study used the GLOBOCAN 2020 database for global epidemiological assessment of new cases and deaths due to invasive melanoma. Main Outcomes and Measures: Age-standardized incidence and mortality rates were calculated per 100 000 person-years by country, world region, and 4-tier level of human development. Estimated numbers of cases and deaths were calculated for the year 2040. Results: A worldwide total of 325 000 new melanoma cases (174 000 males, 151 000 females) and 57 000 deaths (32 000 males, 25 000 females) was estimated for 2020. Large geographic variations existed across countries and world regions, with the highest incidence rates among males (42 per 100 000 person-years) and females (31 per 100 000 person-years) observed in Australia/New Zealand, followed by Western Europe (19 per 100 000 person-years for males and females), North America (18 per 100 000 person-years for males, 14 per 100 000 person-years for females), and Northern Europe (17 per 100 000 person-years for males, 18 per 100 000 person-years for females). Melanoma continued to be rare in most African and Asian countries, with incidence rates commonly less than 1 per 100 000 person-years. Mortality rates peaked at 5 per 100 000 person-years in New Zealand, and geographic variations were less pronounced than for incidence. Melanoma was more frequent among males than females in most world regions. If 2020 rates continue, the burden from melanoma is estimated to increase to 510 000 new cases (a roughly 50% increase) and to 96 000 deaths (a 68% increase) by 2040. Conclusions and Relevance: This epidemiological assessment suggests that melanoma remains an important challenge to cancer control and public health globally, especially in fair-skinned populations of European descent.
Importance: Despite many cases being preventable, cutaneous melanoma remains the most serious skin cancer worldwide. Understanding the scale and profile of the disease is vital to concentrate and reinforce global prevention efforts. Objective: To examine global patterns of cutaneous melanoma in 2020 and to provide projected estimates of cases and deaths by 2040. Design, Setting, and Participants: This population-based study used the GLOBOCAN 2020 database for global epidemiological assessment of new cases and deaths due to invasive melanoma. Main Outcomes and Measures: Age-standardized incidence and mortality rates were calculated per 100 000 person-years by country, world region, and 4-tier level of human development. Estimated numbers of cases and deaths were calculated for the year 2040. Results: A worldwide total of 325 000 new melanoma cases (174 000 males, 151 000 females) and 57 000 deaths (32 000 males, 25 000 females) was estimated for 2020. Large geographic variations existed across countries and world regions, with the highest incidence rates among males (42 per 100 000 person-years) and females (31 per 100 000 person-years) observed in Australia/New Zealand, followed by Western Europe (19 per 100 000 person-years for males and females), North America (18 per 100 000 person-years for males, 14 per 100 000 person-years for females), and Northern Europe (17 per 100 000 person-years for males, 18 per 100 000 person-years for females). Melanoma continued to be rare in most African and Asian countries, with incidence rates commonly less than 1 per 100 000 person-years. Mortality rates peaked at 5 per 100 000 person-years in New Zealand, and geographic variations were less pronounced than for incidence. Melanoma was more frequent among males than females in most world regions. If 2020 rates continue, the burden from melanoma is estimated to increase to 510 000 new cases (a roughly 50% increase) and to 96 000 deaths (a 68% increase) by 2040. Conclusions and Relevance: This epidemiological assessment suggests that melanoma remains an important challenge to cancer control and public health globally, especially in fair-skinned populations of European descent.
Authors: M Arnold; C Holterhues; L M Hollestein; J W W Coebergh; T Nijsten; E Pukkala; B Holleczek; L Tryggvadóttir; H Comber; M J Bento; Ch S Diba; R Micallef; M Primic-Žakelj; M I Izarzugaza; J Perucha; R Marcos-Gragera; J Galceran; E Ardanaz; R Schaffar; A Pring; E de Vries Journal: J Eur Acad Dermatol Venereol Date: 2013-08-21 Impact factor: 6.166
Authors: A Waldmann; S Nolte; M A Weinstock; E W Breitbart; N Eisemann; A C Geller; R Greinert; B Volkmer; A Katalinic Journal: Br J Cancer Date: 2012-01-31 Impact factor: 7.640
Authors: Catherine M Olsen; Louise F Wilson; Adele C Green; Christopher J Bain; Lin Fritschi; Rachel E Neale; David C Whiteman Journal: Aust N Z J Public Health Date: 2015-10 Impact factor: 2.939
Authors: Alexander J Stratigos; Paola Ghiorzo; Kevin M Brown; Susana Puig; Eduardo Nagore; Maria Teresa Landi; D Timothy Bishop; Stuart MacGregor; Mitchell J Machiela; Myriam Brossard; Donato Calista; Jiyeon Choi; Maria Concetta Fargnoli; Tongwu Zhang; Monica Rodolfo; Adam J Trower; Chiara Menin; Jacobo Martinez; Andreas Hadjisavvas; Lei Song; Irene Stefanaki; Richard Scolyer; Rose Yang; Alisa M Goldstein; Miriam Potrony; Katerina P Kypreou; Lorenza Pastorino; Paola Queirolo; Cristina Pellegrini; Laura Cattaneo; Matthew Zawistowski; Pol Gimenez-Xavier; Arantxa Rodriguez; Lisa Elefanti; Siranoush Manoukian; Licia Rivoltini; Blair H Smith; Maria A Loizidou; Laura Del Regno; Daniela Massi; Mario Mandala; Kiarash Khosrotehrani; Lars A Akslen; Christopher I Amos; Per A Andresen; Marie-Françoise Avril; Esther Azizi; H Peter Soyer; Veronique Bataille; Bruna Dalmasso; Lisa M Bowdler; Kathryn P Burdon; Wei V Chen; Veryan Codd; Jamie E Craig; Tadeusz Dębniak; Mario Falchi; Shenying Fang; Eitan Friedman; Sarah Simi; Pilar Galan; Zaida Garcia-Casado; Elizabeth M Gillanders; Scott Gordon; Adele Green; Nelleke A Gruis; Johan Hansson; Mark Harland; Jessica Harris; Per Helsing; Anjali Henders; Marko Hočevar; Veronica Höiom; David Hunter; Christian Ingvar; Rajiv Kumar; Julie Lang; G Mark Lathrop; Jeffrey E Lee; Xin Li; Jan Lubiński; Rona M Mackie; Maryrose Malt; Josep Malvehy; Kerrie McAloney; Hamida Mohamdi; Anders Molven; Eric K Moses; Rachel E Neale; Srdjan Novaković; Dale R Nyholt; Håkan Olsson; Nicholas Orr; Lars G Fritsche; Joan Anton Puig-Butille; Abrar A Qureshi; Graham L Radford-Smith; Juliette Randerson-Moor; Celia Requena; Casey Rowe; Nilesh J Samani; Marianna Sanna; Dirk Schadendorf; Hans-Joachim Schulze; Lisa A Simms; Mark Smithers; Fengju Song; Anthony J Swerdlow; Nienke van der Stoep; Nicole A Kukutsch; Alessia Visconti; Leanne Wallace; Sarah V Ward; Lawrie Wheeler; Richard A Sturm; Amy Hutchinson; Kristine Jones; Michael Malasky; Aurelie Vogt; Weiyin Zhou; Karen A Pooley; David E Elder; Jiali Han; Belynda Hicks; Nicholas K Hayward; Peter A Kanetsky; Chad Brummett; Grant W Montgomery; Catherine M Olsen; Caroline Hayward; Alison M Dunning; Nicholas G Martin; Evangelos Evangelou; Graham J Mann; Georgina Long; Paul D P Pharoah; Douglas F Easton; Jennifer H Barrett; Anne E Cust; Goncalo Abecasis; David L Duffy; David C Whiteman; Helen Gogas; Arcangela De Nicolo; Margaret A Tucker; Julia A Newton-Bishop; Ketty Peris; Stephen J Chanock; Florence Demenais; Jianxin Shi; Mark M Iles; Matthew H Law Journal: Nat Genet Date: 2020-04-27 Impact factor: 38.330
Authors: Juliana Berk-Krauss; Jennifer A Stein; Jeffrey Weber; David Polsky; Alan C Geller Journal: Am J Public Health Date: 2020-03-19 Impact factor: 9.308
Authors: J Ferlay; M Colombet; I Soerjomataram; C Mathers; D M Parkin; M Piñeros; A Znaor; F Bray Journal: Int J Cancer Date: 2018-12-06 Impact factor: 7.396
Authors: Rodolfo David Palacios-Diaz; Blanca de Unamuno-Bustos; Carlos Abril-Pérez; Mónica Pozuelo-Ruiz; Javier Sánchez-Arraez; Ignacio Torres-Navarro; Rafael Botella-Estrada Journal: J Clin Med Date: 2022-04-22 Impact factor: 4.964
Authors: Ida M Heerfordt; Jeppe D Andersen; Peter A Philipsen; Linnea Langhans; Torben Tvedebrink; Grethe Schmidt; Thomas Poulsen; Catharina M Lerche; Niels Morling; Hans Christian Wulf Journal: PLoS One Date: 2022-09-21 Impact factor: 3.752